These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20351549)

  • 1. Cardiac biomarkers - the old and the new: a review.
    Singh V; Martinezclark P; Pascual M; Shaw ES; O'Neill WW
    Coron Artery Dis; 2010 Jun; 21(4):244-56. PubMed ID: 20351549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in acute coronary syndrome and percutaneous coronary intervention.
    Searle J; Danne O; Müller C; Mockel M
    Minerva Cardioangiol; 2011 Jun; 59(3):203-23. PubMed ID: 21516070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac biomakers for the evaluation of acute coronary syndrome.
    Rodriguez-Ospina LF; Rosales-Alvarez CP; Lopez-Mas A
    Bol Asoc Med P R; 2009; 101(4):15-22. PubMed ID: 20853555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new definition for acute myocardial infarction].
    Zahger D; Hod H
    Harefuah; 2004 Apr; 143(4):270-1, 318. PubMed ID: 15116583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department.
    Amodio G; Antonelli G; Varraso L; Ruggieri V; Di Serio F
    Coron Artery Dis; 2007 May; 18(3):181-6. PubMed ID: 17429291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Markers of myocardial damage in the diagnosis of acute myocardial infarction: the Italian reality in the year 2000].
    Ottani F; Galvani M; Dolci A; Plebani M; Tubaro M; Zaninotto M; Panteghini M;
    Ital Heart J Suppl; 2002 Sep; 3(9):933-42. PubMed ID: 12407862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New perspectives in the diagnostic approach to acute coronary syndrome].
    Montagnana M; Lippi G; Guidi GC
    Recenti Prog Med; 2005 Apr; 96(4):171-7. PubMed ID: 15932030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers in the diagnosis of coronary artery disease.
    Hartmann F; Kampmann M; Frey N; Müller-Bardorff M; Katus HA
    Eur Heart J; 1998 Nov; 19 Suppl N():N2-7. PubMed ID: 9857931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A window into your heart: taking cardiac troponin to the next level.
    Hallén J; Atar D
    Biomark Med; 2010 Dec; 4(6):889-94. PubMed ID: 21133709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
    Wiviott SD; de Lemos JA; Morrow DA
    Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential protein biomarker expression and their time-course in patients with a spectrum of stable and unstable coronary syndromes in the Integrated Biomarker and Imaging Study-1 (IBIS-1).
    Wykrzykowska JJ; Garcia-Garcia HM; Goedhart D; Zalewski A; Serruys PW
    Int J Cardiol; 2011 May; 149(1):10-6. PubMed ID: 20060182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
    Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
    Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical markers in the diagnosis of acute coronary syndrome].
    Romić E; Unić A; Derek L; Pehar M
    Acta Med Croatica; 2009 Feb; 63(1):15-9. PubMed ID: 19681456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.